Imunon, Inc. (IMNN)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
May 07, 11:53
Imunon Cash from Investing (Quarterly) : -0.0036M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Savara, Inc. | -93.56M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Corcept Therapeutics, Inc. | 4.542M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.657M |
| Cash from Financing (Quarterly) | 7.191M |
| Free Cash Flow | -14.18M |
| Free Cash Flow Per Share (Quarterly) | -1.120 |
| Free Cash Flow to Equity (Quarterly) | -3.567M |
| Free Cash Flow to Firm (Quarterly) | -3.661M |
| Free Cash Flow Yield | -93.40% |